277 related articles for article (PubMed ID: 10440088)
21. Safety, tolerability, and pharmacokinetics of SR 49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteers.
Brouard R; Laporte V; Serradeil Le Gal C; Pignol R; Jang H; Donat F; Lockwood G; Fournie D; Dreux F
Adv Exp Med Biol; 1998; 449():455-65. PubMed ID: 10026839
[TBL] [Abstract][Full Text] [Related]
22. Effect of oxytocin as a partial agonist at vasoconstrictor vasopressin receptors on the human isolated uterine artery.
Jovanović A; Jovanović S; Tulić I; Grbović L
Br J Pharmacol; 1997 Aug; 121(7):1468-74. PubMed ID: 9257929
[TBL] [Abstract][Full Text] [Related]
23. Characterization of arginine vasopressin actions in human uterine artery: lack of role of the vascular endothelium.
Jovanović A; Grbović L; Zikić I; Tulic I
Br J Pharmacol; 1995 Aug; 115(7):1295-301. PubMed ID: 7582559
[TBL] [Abstract][Full Text] [Related]
24. Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans.
Weber R; Pechère-Bertschi A; Hayoz D; Gerc V; Brouard R; Lahmy JP; Brunner HR; Burnier M
Hypertension; 1997 Nov; 30(5):1121-7. PubMed ID: 9369265
[TBL] [Abstract][Full Text] [Related]
25. Effect of the non-peptide, vasopressin V1a receptor antagonist, SR 49059 and its enantiomer, SR 49770, on isolated human myometrium.
Bossmar T; Rasmussen T; Akerlund M
Acta Obstet Gynecol Scand; 1996 Jul; 75(6):516-9. PubMed ID: 8693925
[TBL] [Abstract][Full Text] [Related]
26. Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells.
Perdonà E; Arban R; Griffante C
Eur J Pharmacol; 2012 Mar; 679(1-3):16-23. PubMed ID: 22285855
[TBL] [Abstract][Full Text] [Related]
27. V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones.
Gouzénes L; Sabatier N; Richard P; Moos FC; Dayanithi G
J Physiol; 1999 Jun; 517 ( Pt 3)(Pt 3):771-9. PubMed ID: 10358117
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide, but not vasopressin V2 receptor-mediated vasodilation, modulates vasopressin-induced renal vasoconstriction in rats.
Loichot C; Cazaubon C; De Jong W; Helwig JJ; Nisato D; Imbs JL; Barthelmebs M
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):319-26. PubMed ID: 10731046
[TBL] [Abstract][Full Text] [Related]
29. Effects of SR 49059, a non-peptide antagonist of vasopressin V1a receptors, on vasopressin-induced coronary vasoconstriction in conscious rabbits.
Serradeil-Le Gal C; Villanova G; Boutin M; Maffrand JP; Le Fur G
Fundam Clin Pharmacol; 1995; 9(1):17-24. PubMed ID: 7768483
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women.
Steinwall M; Bossmar T; Gaud C; Akerlund M
Acta Obstet Gynecol Scand; 2004 Jan; 83(1):12-8. PubMed ID: 14678081
[TBL] [Abstract][Full Text] [Related]
31. [Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists.
Bax WA; Van der Graaf PH; Stam WB; Bos E; Nisato D; Saxena PR
Eur J Pharmacol; 1995 Oct; 285(2):199-202. PubMed ID: 8566139
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of angiotensin, vasopressin and oxytocin on various smooth muscle tissues within the human uteroplacental unit.
Maigaard S; Forman A; Andersson KE
Acta Physiol Scand; 1986 Sep; 128(1):23-31. PubMed ID: 3766172
[TBL] [Abstract][Full Text] [Related]
33. Oxytocin-induced contractions within rat and rabbit ejaculatory tissues are mediated by vasopressin V1A receptors and not oxytocin receptors.
Gupta J; Russell R; Wayman C; Hurley D; Jackson V
Br J Pharmacol; 2008 Sep; 155(1):118-26. PubMed ID: 18552879
[TBL] [Abstract][Full Text] [Related]
34. Oxytocin does not directly affect vascular tone in vessels from nonpregnant and pregnant rats.
Miller ME; Davidge ST; Mitchell BF
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1223-8. PubMed ID: 11893555
[TBL] [Abstract][Full Text] [Related]
35. Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor.
Cirillo R; Gillio Tos E; Schwarz MK; Quattropani A; Scheer A; Missotten M; Dorbais J; Nichols A; Borrelli F; Giachetti C; Golzio L; Marinelli P; Thomas RJ; Chevillard C; Laurent F; Portet K; Barberis C; Chollet A
J Pharmacol Exp Ther; 2003 Jul; 306(1):253-61. PubMed ID: 12660315
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women.
Pierzynski P; Lemancewicz A; Reinheimer T; Akerlund M; Laudanski T
J Soc Gynecol Investig; 2004 Sep; 11(6):384-7. PubMed ID: 15350251
[TBL] [Abstract][Full Text] [Related]
37. Oxytocin and vasopressin V(1A) receptors as new therapeutic targets in assisted reproduction.
Pierzynski P
Reprod Biomed Online; 2011 Jan; 22(1):9-16. PubMed ID: 21130036
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of the biological effects of neurohypophysial peptides on seminiferous tubules.
Harris GC; Nicholson HD
J Endocrinol; 1998 Jan; 156(1):35-42. PubMed ID: 9496231
[TBL] [Abstract][Full Text] [Related]
39. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
40. Vasopressin effects on isolated non-pregnant myometrium and uterine arteries and their inhibition by deamino-ethyl-lysine-vasopressin and deamino-ethyl-oxytocin.
Akerlund M; Kostrzewska A; Laudănski T; Melin P; Vilhardt H
Br J Obstet Gynaecol; 1983 Aug; 90(8):732-8. PubMed ID: 6882706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
